Sense and Anti-Sense: Role of FAM83A and FAM83A-AS1 in Wnt, EGFR, PI3K, EMT Pathways and Tumor Progression

Chenshu Zhao,Xiaowen Li,Rui Zhang,Hao Lyu,Shuai Xiao,Dong Guo,Declan William Ali,Marek Michalak,Xing-Zhen Chen,Cefan Zhou,Jingfeng Tang
DOI: https://doi.org/10.1016/j.biopha.2024.116372
IF: 7.419
2024-01-01
Biomedicine & Pharmacotherapy
Abstract:An increasing number of studies have shown that FAM83A, a member of the family with sequence similarity 83 (FAM83), which consists of eight members, is a key tumor therapeutic target involved in multiple signaling pathways. It has been reported that FAM83A plays essential roles in the regulation of Wnt/β-catenin, EGFR, MAPK, EMT, and other signaling pathways and physiological processes in models of pancreatic cancer, lung cancer, breast cancer, and other malignant tumors. Moreover, the expression of FAM83A could be significantly affected by multiple noncoding RNAs that are dysregulated in malignant tumors, the dysregulation of which is essential for the malignant process. Among these noncoding RNAs, the most noteworthy is the antisense long noncoding (Lnc) RNA of FAM83A itself (FAM83A-AS1), indicating an outstanding synergistic carcinogenic effect between FAM83A and FAM83A-AS1. In the present study, the specific mechanisms by which FAM83A and FAM83A-AS1 cofunction in the Wnt/β-catenin and EGFR signaling pathways were reviewed in detail, which will guide subsequent research. We also described the applications of FAM83A and FAM83A-AS1 in tumor therapy and provided a certain theoretical basis for subsequent drug target development and combination therapy strategies.
What problem does this paper attempt to address?